Trials Review: Cardiovascular Outcome with Intensive Glycemic Control and Implications for Patients with Type 2 Diabetes

References

• . Selvin E, Marinopoulos S, Berkenblit G, . Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421–431
   PubMed Web of Science ®Google Scholar
• . DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care. 2003;26(3):688–696
   PubMed Web of Science ®Google Scholar
• . Teuscher AU, Reinli K, Teuscher A. Prevalence of diabetes mellitus and impaired glucose in elderly European subjects. Diabetes. 1999;(48 suppl 1):395–396
   Google Scholar
• . Lindeman RD, Romero LJ, Hundley R, . Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly biethnic population. Diabetes Care. 1998;21(6):959–966
   PubMed Web of Science ®Google Scholar
• . Chin MH, Zhang JX, Merrel K. Speciality differences in the care of older patients with diabetes. Med Care. 2000;38(2):131–140
   PubMed Web of Science ®Google Scholar
• . Abrahamson MJ. A 74-year-old woman with diabetes. JAMA. 2007;297(2):196–204
   PubMed Web of Science ®Google Scholar
• . Hayward RA, Hofer TP, Vijan S. Intensive glucose control in elderly adults. JAMA. 2007;297(20):2195
   PubMedGoogle Scholar
• . University Group Diabetes Program. I; design and baseline results methods. Diabetes. 1970;19( suppl 2):747–783
   Web of Science ®Google Scholar
• . Meinert CL, Knatteraud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complictions in patients with adult-onset diabetes. II. Mortality results. Diabetes. 1970;19( suppl):789–830
   PubMed Web of Science ®Google Scholar
• . Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes. 1982;31( suppl 5):1–81
   Google Scholar
• . Ohkubo Y, Kishikawa H, Araki E, . Intensive insulin therapy prevents the progression of diabetic microvasular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117
   PubMed Web of Science ®Google Scholar
• . Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23( suppl 2):B21–B29
   PubMed Web of Science ®Google Scholar
• . Abraira C, Colwell J, Nuttall F, . Cardiovascular events and correlates in the Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997;157(2):181–188
   PubMedGoogle Scholar
• . Duckworth W, Abraira C, Moritz T, .; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139
   PubMed Web of Science ®Google Scholar
• . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853
   PubMed Web of Science ®Google Scholar
• . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854–865
   PubMed Web of Science ®Google Scholar
• . Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and micro-albuminuria: the Steno type 2 randomised study. Lancet. 1999;353(9153):617–622
   PubMed Web of Science ®Google Scholar
• . ; ADVANCE Collaborative GroupPatel A, MacMahon S, Chalmers J, . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572
   PubMed Web of Science ®Google Scholar
• . ; Action to Control Cardiovascular Risk in Diabetes Study GroupGerstein HC, Miller ME, Byington RP, . Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559
   PubMed Web of Science ®Google Scholar
• . Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589
   PubMed Web of Science ®Google Scholar
• . Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383–393
   PubMed Web of Science ®Google Scholar
• . Gaede P, Lund-Anderson H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591
   PubMed Web of Science ®Google Scholar
• . Nathan DM, Cleary PA, Backlund JY, .; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–2653
   PubMed Web of Science ®Google Scholar
• . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–986
   PubMed Web of Science ®Google Scholar
• . Ray KK, Seshasai SR, Wijesuriya S, . Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765–1772
   PubMed Web of Science ®Google Scholar
• . Blaum CS, Volpato S, Cappola AR, . Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I. Diabet Med. 2005;22(5):543–550
   PubMed Web of Science ®Google Scholar
• . Schwartz AV, Vittinghoff E, Sellmeyer DE, .; Health, Aging, and Body Composition Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008;31(3):391–396
   PubMed Web of Science ®Google Scholar
• . Pham M, Pinganaud G, Richard-Harston S, Decamps A, Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab. 2003;29(3):251–258
   PubMed Web of Science ®Google Scholar
• . Cukierman-Yaffe T, Gerstein HC, Williamson JD, .; Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009;32(2):221–226
   PubMed Web of Science ®Google Scholar
• . Abdelhafiz AH, Sinclair AJ. Hypoglycaemia in residential care homes. Br J Gen Pract. 2009;59(558):49–50
   PubMed Web of Science ®Google Scholar
• . Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med. 2008;149(1):11–19
   PubMed Web of Science ®Google Scholar